Validation and noninvasive kinetic modeling of [ 11 C]UCB-J PET imaging in mice
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Synaptic pathology is associated with several brain disorders, thus positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) using the radioligand [ 11 C]UCB-J may provide a tool to measure synaptic alterations. Given the pivotal role of mouse models in understanding neuropsychiatric and neurodegenerative disorders, this study aims to validate and characterize [ 11 C]UCB-J in mice. We performed a blocking study to verify the specificity of the radiotracer to SV2A, examined kinetic models using an image-derived input function (IDIF) for quantification of the radiotracer, and investigated the in vivo metabolism. Regional TACs during baseline showed rapid uptake of [ 11 C]UCB-J into the brain. Pretreatment with levetiracetam confirmed target engagement in a dose-dependent manner. V T (IDIF) values estimated with one- and two-tissue compartmental models (1TCM and 2TCM) were highly comparable (r=0.999, p < 0.0001), with 1TCM performing better than 2TCM for K 1 (IDIF) . A scan duration of 60 min was sufficient for reliable V T (IDIF) and K 1 (IDIF) estimations. In vivo metabolism of [ 11 C]UCB-J was relatively rapid, with a parent fraction of 22.5 ± 4.2% at 15 min p.i. In conclusion, our findings show that [ 11 C]UCB-J selectively binds to SV2A with optimal kinetics in the mouse representing a promising tool to noninvasively quantify synaptic density in comparative or therapeutic studies in neuropsychiatric and neurodegenerative disorder models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Validation of [11C]UCB-J binding in the mouse brain. (a) Effect of blockade with levetiracetam (LEV) on [11C]UCB-J uptake in WT mice. Parametric microPET images are overlaid onto a MRI mouse brain template for anatomical localization. (b) SUV time-activity curves in four brain regions during baseline and pretreatment with levetiracetam for a 90-min acquisition. (c) VT (IDIF) (Logan) quantification during blockade resulted in a statistically significant reduced values in all investigated regions compared to baseline. ****p < 0.0001. Baseline: n = 10; LEV: n = 4 per dose. STR: striatum; THAL: thalamus; MC: motor cortex; HC: hippocampus; VT (IDIF): total volume of distribution using IDIF.](https://figures.cochat.ai/paper-figures/215132e076594df7be559dea38607251/validation-and-noninvasive-kinetic-modeling-of-sup-11-sup-c-ucb-j-pet-imaging-in-figure-1.jpg)

![Figure 3. [11C]UCB-J PET imaging in the mouse brain. (a) Average microPET parametric images for VT (IDIF) and K1 (IDIF) of [11C]UCB-J in healthy WT mice using 1TCM over 90-min acquisition. Parametric microPET images are overlaid onto a MRI mouse brain template for anatomical localization. (b) Regional [11C]UCB-J VT (IDIF) values. (c) Regional [11C]UCB-J K1 (IDIF) values. n = 10. 1TCM: one-tissue compartmental model; VT (IDIF) : total volume of distribution using IDIF; STR: striatum; TH: thalamus; MC: motor cortex; HC: hippocampus; CB: cerebellum.](https://figures.cochat.ai/paper-figures/1527757ee553411fa175f68ac57bb5cf/validation-and-noninvasive-kinetic-modeling-of-sup-11-sup-c-ucb-j-pet-imaging-in-figure-3.jpg)

![Figure 5. Population-based plasma metabolism of [11C]UCB-J in mice. (a) Population-based curve of intact [11C]UCB-J in plasma of healthy wild-type (WT) and diseased (model of Huntington's disease, HD) mice. n = 3 per genotype at each time point. (b) Sigmoid fitting curve of the intact [11C]UCB-J in WT mice. (c) Comparison of representative image-derived input functions (IDIF) corrected and uncorrected for the population-based sigmoid fitting of intact [11C]UCB-J. Scatter plots between VT (IDIF) (Logan) corrected and uncorrected for the population-based sigmoid fitting of intact [11C]UCB-J based on a total of five WT mice (d) and correlations for each individual WT mouse (e) in different brain regions. Individual animals presented different regression line equations.](https://figures.cochat.ai/paper-figures/9d323771a81c422a97527c3088903948/validation-and-noninvasive-kinetic-modeling-of-sup-11-sup-c-ucb-j-pet-imaging-in-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The metabolism of our radioligand that has been verified in additional mice per group was in line with the recent study published by Bertoglio18 and seems to exclude a potential effect of fluoxetine on cytochrome.”
From Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“For the case of radiometabolites, a population-based metabolite correction could be a solution [157,158], but ideally this should be established for each tracer and validated in each animal model [152].”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [157]
The cited source says what the claim attributes to it.
In the citing paper
“This method has successfully been applied by Bertoglio et al. to estimate [ 11 C]UCB-J [157] and [ 18 F] SynVesT-1 [158] V T values in mice.”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Molecular machines governing exocytosis of synaptic vesicles
Jahn, R., & Fasshauer, D. (2012) · Nature · doi:10.1038/nature11320 · Cited by 970
Imaging synaptic density in the living human brain
Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6667 · Cited by 575 · cited 1×
“[(11)C]UCB-J appears the most promising due to its optimal pharmacokinetics and quantification properties as recently reported in both non-human primates(11) and healthy humans.(15,16) In addition, recent studies have demonstrated the feasibility of [(11)C]UCB-J PET in detecting pathological changes in synaptic densit…”
BackgroundLower synaptic density is associated with depression severity and network alterations
Holmes, S. E., Scheinost, D., Finnema, S. J., Naganawa, M., Davis, M. T., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G. A., Pietrzak, R. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09562-7 · Cited by 484
Differential expression of synaptic vesicle protein 2 (SV2) isoforms
Bajjalieh, S., Frantz, G., Weimann, J., McConnell, S., & Scheller, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05223.1994 · Cited by 440
Chen, M.-K., Mecca, A. P., Naganawa, M., Finnema, S. J., Toyonaga, T., Lin, S.-F., Najafzadeh, S., Ropchan, J., Lu, Y., McDonald, J. W., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1836 · Cited by 431
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415 · cited 1×
“Indeed, SV2A is expressed ubiquitously in virtually all synapses(3) and its role has been shown to be vital as mice lacking SV2A develop spontaneous seizures and die postnatally due to destabilization of synaptic circuits.(4,6) In addition, SV2A is the binding site of the antiepileptic drug levetiracetam (LEV)(7) and…”
Background
Research works printed but not linked: 1
- Fox J, Barthold S, Davisson M, et al. The mouse in biomedical research, 2nd ed. Amsterdam: Elsevier, 2006, pp. 2192.
Cited by
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123
“Preclinical studies have been performed to evaluate [11C]UCB-J PET in different animal models, including mice (Bertoglio et al., 2020), rats (Thomsen et al., 2021b) and minipigs (Thomsen et al., 2020).”
Nerella, S. G., Bhattacharya, A., Joshi, R. K., Nagaraj, C., Bharath, R. D., & Kumar, P. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01053 · Cited by 60
Synaptic Loss in Frontotemporal Dementia Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Malpetti, M., Jones, P. S., Cope, T. E., Holland, N., Naessens, M., Rouse, M. A., Rittman, T., Savulich, G., Whiteside, D. J., Street, D., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26543 · Cited by 53
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing
Manabe, T., Rácz, I., Schwartz, S., Oberle, L., Santarelli, F., Emmrich, J. V., Neher, J. J., & Heneka, M. T. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15491 · Cited by 44
Thomsen, M. B., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M., Romero-Ramos, M., Brooks, D. J., & Landau, A. M. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20931140 · Cited by 38
“In one [11C] UCB-J study, an input function was generated by imaging total blood radioactivity of the heart sampling activity with a volume of interest over the left ventricle.(9) In contrast to rat PET imaging studies, the small size of the mouse allows a larger PET field of view and activity of both brain and the he…”
Method
Metadata
- Authors
- Bertoglio, D., Verhaeghe, J., Miranda, A., Kertesz, I., Cybulska, K., Korat, Š., Wyffels, L., Stroobants, S., Mrzljak, L., Dominguez, C., Liu, L., Skinbjerg, M., Munoz-Sanjuan, I., & Staelens, S.
- Affiliations
- University of Antwerp (BE)
- Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium
- CHDI Foundation (US)
- CHDI Management/CHDI Foundation, Los Angeles, CA, USA
- Corresponding author
- Staelens, Steven
- ORCID
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2019-07-15
- Volume
- 40
- Issue
- 6
- Pages
- 1351-1362
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC7232782
- OpenAlex
- W2958717266
- Cited by
- 54
- References
- 38
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 6 · 2023: 6 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 2
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- Funders
- Universiteit Antwerpen
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- [11C]UCB-J, SV2A, image-derived input function, radiotracer kinetics, target engagement, mouse model, compartmental kinetic model
- MeSH terms
- Animals, Brain, Image Processing, Computer-Assisted, Kinetics, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Models, Theoretical, Nerve Tissue Proteins, Pyridines, Pyrrolidinones, Synaptic Vesicles, Radiopharmaceuticals, Positron-Emission Tomography, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Validation and noninvasive kinetic modeling of [ 11 C]UCB-J PET imaging in mice. https://app.cochat.ai/papers/10.1177/0271678x19864081
- The paper
- Bertoglio, D., Verhaeghe, J., Miranda, A., Kertesz, I., Cybulska, K., Korat, Š., Wyffels, L., Stroobants, S., Mrzljak, L., Dominguez, C., Liu, L., Skinbjerg, M., Munoz-Sanjuan, I., & Staelens, S. (2020). Validation and noninvasive kinetic modeling of [ 11 C]UCB-J PET imaging in mice. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x19864081
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.